|
|
The 3rd Pharmaceutical & Biotechnology Pioneer Forum 2010 is recognized as one of the most important high-level pharmaceutical & biotechnology conferences in China. This year the conference program will focus on open innovation, licensing opportunities, RNAi, clinical developments antibody and the best opportunities for R&D partnering. It will provide attendees with a unique platform to examine and benefit from key issues. The event will also help to boost the growth of companies in China. The summit will serve as forum for discussion and determination of real issues and to create fresh business relationship. Participants will get the chance to explore the new R&D metrics in the post-blockbuster era. They will also learn to screen, implement, evaluate, and negotiate the right external improvement openings. The event will highlight the latest trends in licensing and partnering deals in special markets like China.
The conference will discuss on key topics including:
- Innovative drug discovery and clinical trials outsourcing opportunities in Asia
- Venturing into new scientific and therapeutic areas
- Latest trends in partnering and licensing deals
- New R&D metrics and open innovation
Visitor Profile
The targeted visitors at the 3rd Pharmaceutical & Biotechnology Pioneer Forum would include Presidents, Vice Presidents, Directors, Senior Managers, Managers and Scientific Officers associated with:
- Research & Development
- Sales and Marketing
- External Innovation
- External Research
- Pre-clinical Development
- Global Sourcing
- Corporate Strategy
- Business Development
- Mergers and Acquisitions
- Clinical Trials
- Strategic Alliance
- Global Licensing
- Intellectual Property & Patents
Organizer
Genview Consulting Ltd
